Goldman Sachs Maintains Agilon Health Buy Recommendation

Fintel reports that on May 31, 2023, Goldman Sachs maintained coverage of Agilon Health (NYSE:AGL) with a Buy recommendation.

Analyst Price Forecast Suggests 52.47% Upside

As of May 11, 2023, the average one-year price target for Agilon Health is 30.87. The forecasts range from a low of 22.72 to a high of $43.05. The average price target represents an increase of 52.47% from its latest reported closing price of 20.25.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Agilon Health is 3,950MM, an increase of 23.79%. The projected annual non-GAAP EPS is -0.01.

What is the Fund Sentiment?

There are 505 funds or institutions reporting positions in Agilon Health. This is an increase of 24 owner(s) or 4.99% in the last quarter. Average portfolio weight of all funds dedicated to AGL is 0.40%, an increase of 2.10%. Total shares owned by institutions increased in the last three months by 3.36% to 520,506K shares. The put/call ratio of AGL is 0.37, indicating a bullish outlook.

What are Other Shareholders Doing?

Clayton, Dubilier & Rice holds 194,611K shares representing 46.91% ownership of the company. No change in the last quarter.

Capital World Investors holds 42,436K shares representing 10.23% ownership of the company. In it’s prior filing, the firm reported owning 37,918K shares, representing an increase of 10.65%. The firm increased its portfolio allocation in AGL by 59.68% over the last quarter.

Wellington Management Group Llp holds 20,346K shares representing 4.90% ownership of the company. In it’s prior filing, the firm reported owning 22,745K shares, representing a decrease of 11.79%. The firm decreased its portfolio allocation in AGL by 81.64% over the last quarter.

ANEFX – NEW ECONOMY FUND holds 14,503K shares representing 3.50% ownership of the company. In it’s prior filing, the firm reported owning 11,897K shares, representing an increase of 17.97%. The firm increased its portfolio allocation in AGL by 46.69% over the last quarter.

VGHCX – Vanguard Health Care Fund Investor Shares holds 14,265K shares representing 3.44% ownership of the company. No change in the last quarter.

Agilon Health Background Information
(This description is provided by the company.)

agilon health is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. agilon health enables physicians to create their own Medicare-centric globally capitated line of business. The agilon Total Care Model is powered by its purpose-built platform and enabled through a growing national network of like-minded physician partners. With agilon, physicians are freed from the constraints of the transactional fee-for-service reimbursement model and are able to practice team-based, coordinated care to serve the individual needs of their senior patients and to transition to a sustainable and predictable, long-term business model. The rapidly growing appeal of the agilon platform, partnership model and network of leading community-based physicians has allowed the company to expand to 17 local communities with 16 anchor physician groups, as well as a network of physicians across Hawaii, in fewer than five years.

Key filings for this company:

• UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

This article originally appeared on Fintel